Additionally, studies have shown that BCKDK enhances the MAPK signaling pathway by directly phosphorylating MEK, rather than through branched-chain amino acid catabolism, thereby promoting colorectal cancer progression (Xue et al., 2017). Here, BCKDK is linked to colorectal cancer.